Julie Dechanet-Merville
Directeur/Membre du Conseil chez Lymphact - Lymphocyte Activation Technologies SA
Postes actifs de Julie Dechanet-Merville
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Lymphact - Lymphocyte Activation Technologies SA
 Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Julie Dechanet-Merville
Statistiques
Internationale
| Portugal | 2 |
Opérationnelle
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |
- Bourse
- Insiders
- Julie Dechanet-Merville
- Expérience
